News Focus
News Focus
Followers 58
Posts 5949
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Thursday, 12/04/2025 9:38:49 PM

Thursday, December 04, 2025 9:38:49 PM

Post# of 9182
We know Pfizer, Novartis and Roche all need to fill their depleted pipelines. And they would all like to receive cash flow as soon as possible. But they are also looking for long term platforms to produce many drugs.

And they all know about Capricor. It will produce cash flow in 2026 with its Deramiocel sales.
And it has the StealthX exosome platform which can become the world leading delivery system for both vaccines and therapeutics.

Would Pfizer , Novartis or Roche like to partner with Capricor? Certainly they would! But would they prefer to do a buyout? Probably. Certainly they do not want Deramiocel and StealthX to fall into the hands of their competition! Do you think they will be talking to Capricor? I do!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CAPR News